Standard Biotools (LAB) Interest Expenses (2010 - 2026)

Standard Biotools (LAB) has 17 years of Interest Expenses data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 21.5% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 21.5% increase from a year earlier, with the FY2025 full-year figure at $289.4 million, down 4.93% from the prior year.
• Interest Expenses for Q1 2026 stood at $4.4 million, up from $11000.0 in the prior quarter.
• Over the last five years, Interest Expenses for LAB reached as high as $50.7 million in Q1 2024 and fell as low as $10000.0 in Q2 2025.
• Historically, Interest Expenses has averaged $7.8 million across 5 years, with a median of $1.3 million in 2022.
• Across the five-year window, Interest Expenses soared 5968.78% in 2024 and tumbled 99.98% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $1.2 million in 2022, then jumped by 38.49% to $1.6 million in 2023, then soared by 221.42% to $5.3 million in 2024, then sank by 99.79% to $11000.0 in 2025, then jumped by 39554.55% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $4.4 million in Q1 2026, $11000.0 in Q4 2025, and $10000.0 in Q3 2025.